Menu
Not yet recruiting NCT07202806

A Study on the Application of Aromatherapy Combined With Transcranial Magnetic Stimulation in Insomnia of Stroke Patients

No phase Interventional Stroke

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Aromatherapy.
Who it may be relevant to
Registry conditions: Stroke. Basic parameters: 24 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Exploring the application efficacy of aromatherapy combined with transcranial magnetic stimulation on insomnia in patients with cerebral stroke

Interventions

  • Behavioral Aromatherapy
    1.Aromatherapy is made from self-made sachet of traditional Chinese medicine.Its components (albizzia, Angelica dahurica, cardamom, Polygala, Evodia, Magnolia, Acorus calamus) are 10g each. Place the pillow 1 hour in advance. It is forbidden to play with your mobile phone or turn off the lights before going to bed.

Primary outcome measures

  • Respiratory sleep monitoring [Time frame: From enrollment to the end of treatment for 3 weeks]
Secondary outcome measures (1)
  • Pittsburgh sleep quality index,PSQI [Time frame: From enrollment to the end of treatment for 3 weeks]

Eligibility criteria

Inclusion criteria

  • Clinical diagnosis of stroke
  • Insomnia patients
  • Sign the informed consent form, cooperate voluntarily
  • Accord with the diagnosis of "insomnia" in traditional Chinese medicine
  • Evaluation has no taboo on transcranial magnetism
  • The age range is between 24 and 65

Exclusion criteria

  • Disturbance of consciousness
  • Cognitive impairment
  • Mental abnormality
  • Sleep apnea syndrome
  • Restless leg syndrome

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Quadruple blind
Primary purpose
Treatment

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07202806 · 2024B1366

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗